• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ADAC, Eastern Isotopes form alliance

Article

ADAC Laboratories has forged an exclusive vendor agreement with PET radiopharmaceutical manufacturer Eastern Isotopes. The partnership gives ADAC access to 5.5 millicurie doses of FDG, which it will buy at a discount from Eastern Isotopes, and allows it

ADAC Laboratories has forged an exclusive vendor agreement with PET radiopharmaceutical manufacturer Eastern Isotopes. The partnership gives ADAC access to 5.5 millicurie doses of FDG, which it will buy at a discount from Eastern Isotopes, and allows it to supply its molecular coincidence detection/attenuation correction (MCD/AC) and CPET customers. ADAC’s FDG imaging products do not require 10 millicurie doses of the radioisotope, as competitive products do, according to the Milpitas, CA, company.

Based in Sterling, VA, Eastern Isotopes was established in 1995 as a distributor of SPECT pharmaceuticals. Last year, the firm began to produce high-energy tracers, particularly FDG, for therapy, oncology, cardiology, and neurology.

With the deal, ADAC continues its push into the PET market, capitalizing on the momentum created by its September purchase of partner UGM Medical, a developer and manufacturer of PET devices (SCAN 9/29/99). The two firms codeveloped ADAC’s MCD high-energy imaging option for gamma cameras (SCAN 12/14/94).

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.